🚀 Stay Updated! 🚀 For the latest insights, news, and updates on icometrix products, follow us on LinkedIn! 👉

Our CTO, @dsmeets, is headed to #ASSR25 in San Diego (Feb 12-15) to share the latest in #AI-powered spinal cord imaging! 🔹 icometrix spinal cord pipeline – deep-learning segmentation for research 🔹 icobrain MS+ – C2-C3 quantification from brain scans 📩 Connect with Dirk! 👋

🔔 @DENT Neurologic Institute partners with icometrix We’re proud to collaborate with DENT, advancing Alzheimer’s care with #FDA-cleared #icobrain aria, the only AI tool for ARIA detection. 🔗 Learn more in the full press release

We're excited to be at #RSNA24 showcasing the release of #icobrain aria! Designed for #radiologists, it’s set to transform medical #imaging 🧠 with deeper insights and efficiency. Don’t miss your chance to connect with us at booth #4093 before #RSNA wraps up! 🤝 #RSNA2024

RT @WendeNGibbs: Wow-Trailblazers! Congratulations to @icometrix for another first… First FDA cleared CADe/CADx- an arduous task for sure.…

RT @dsmeets: BREAKING NEWS. I am incredibly excited to announce the FDA clearance of icobrain aria, as the first and only cleared device fo…

RT @dsmeets: @icometrix has been nominated twice for the #Minnies2024 by @AuntMinnie: the Most Significant News Event in Radiology for th…

📢 icometrix is proud to announce the market approval of #icobrain aria, the first market-approved solution for monitoring amyloid-related imaging abnormalities (#ARIA) in #Alzheimers disease:

Read the incredible journey that led to the new icometrix #CPTcodes (0865T/0866T) in the US! The emphasis on scientific validation & peer-reviewed evidence, deeply ingrained in our DNA from its academic origins, sets a remarkable standard for the industry.

The #actrims2024 Forum kicks off today! Join our National Key Account Director Rebecca Bartz & get the insights of our latest abstract: "A deep learning-based pipeline for cervical spinal cord segmentation and labeling on heterogeneous T1w #brain images."👉

Feb 29th, a rare date, marks #RareDiseaseDay. At icometrix, we're spotlighting our initiatives to enhance care for rare #neurological diseases. With over 300M worldwide affected, every patient matters. Learn about our projects: @ionispharma @StokeTx

📢 Attn. early birds! 🐥 Join us at #ECR2024 Feb.28, as our AI Developer & co-author Ricardo Magalhaes presents our abstract: "A deep learning-based pipeline for cervical #spinal cord segmentation & labeling on heterogeneous T1w brain images." 🧠#icobrain

Exciting developments are reshaping the neuroradiological field! 🚀 Join us in this engaging 5-minutes quiz to stay up to date on recent advancements. 💡Ready to challenge yourself? 👉

🦈 Join our CTO @dsmeets at #ASSR24 today for the AI “Shark Tank” panel on 'Spinning the Future of #Spine #Radiology'. Our latest research has bolstered our spinal cord pipeline. Read our blog "The Progress(ion) in MS" for a refresher: #standardofcare

Robert Hyde stressed standardized #imaging's vital role in #AI, esp. in chronic disease: HCPs & rads benefit when scheduling ensures consistent scanner & sequences for baseline + follow-up scans. #BrainAI

Our groundbreaking research showcases how #icobrain #aria elevates brain #MRI accuracy for monitoring amyloid-related imaging abnormalities in #AD's patients. Illuminating #AI's transformative potential in patient care, spotlighted on @AuntMinnie! 🌟#JAMA

Kudos to our team on the groundbreaking publication in #JAMA! The collab with #Biogen to develop #icobrainaria marks a pivotal advancement in #ARIA detection for #AD's patients. This innovative CADe/CADx software promises to revolutionize ARIA management.

🧠 We're proud to unveil a major stride in pediatric #neuroimaging that holds the potential to revolutionize the journey of young epilepsy patients. The latest update to our #icobrainep automated report is poised to redefine the #EP care landscape of.

On this Intl. Day of Women in Science we shine a spotlight on 2 exceptional women at icometrix, leading the charge in AI neuroimaging. Read the inspiring interview with Annemie Ribbens & Diana Sima, on their journey, achievements & aspirations.👉

Tune into this week's #DataInBiotech podcast episode with our VP Science, Evidence & Trials, Annemie Ribbens! All about transforming patient care for #neurologicaldisorders through #AI solutions. #standardofcare👉Spotify: 👉iTunes: